Evidence map›Paper›PMID 32210835›Full record

ArticleFrontiers in physiology2020

Diabetes Increases the Vulnerability of the Cardiac Mitochondrial Network to Criticality.

Larissa Vetter, Sonia Cortassa, Brian O'Rourke, Antonis A Armoundas, Djahida Bedja, Johann M E Jende, Martin Bendszus, Nazareno Paolocci, Steven J Sollot, Miguel A Aon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Larissa VetterLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Sonia CortassaLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Brian O'RourkeDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Antonis A ArmoundasCardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, United States.
Djahida BedjaDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Johann M E JendeDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Martin BendszusDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
Nazareno PaolocciDivision of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Steven J SollotLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Miguel A AonLaboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Felix T KurzDepartment of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.
National Institutes of Health · USJohns Hopkins Medicine · USMassachusetts General Hospital · USUniversity Hospital Heidelberg · DEJohns Hopkins University · USNational Institute on Aging · US

Funding

BDNF TrkB- and beta-AR signals in ischemic and non-ischemic cardiomyopathyR01HL136918 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PAOLOCCI, NAZARENO · 2018 to 2021
$2.7M
Prevention and Treatment of Ventricular TachyarrhythmiasR01HL135335 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2017 to 2020
$2.1M
Molecular Determinants of Mitochondrial Instability and ArrhythmiasR01HL137259 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI AKAR, FADI GABRIEL, O'ROURKE, BRIAN · 2017 to 2020
$2.0M
Mechanisms Underlying Mitrochondrial Dysfunction in the Diabetic HeartR01HL091923 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI AKAR, FADI GABRIEL, AON, MIGUEL ANTONIO · 2009 to 2012
$1.9M
A Medical-Grade Smart-Phone Based Monitoring System (Supplement)R21EB026164 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2018 to 2020
$668k
Utility of Vagal Stimulation to Prevent the Onset of Ventricular ArrhythmiasR21HL137870 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2017 to 2018
$468k
NHLBI NIH HHS R01 HL091923NHLBI NIH HHS R01 HL135335NHLBI NIH HHS R01 HL136918NHLBI NIH HHS R01 HL137259NHLBI NIH HHS R21 HL137870NIBIB NIH HHS R21 EB026164
6 · The paper itself

Abstract

Mitochondrial criticality describes a state in which the mitochondrial cardiac network under intense oxidative stress becomes very sensitive to small perturbations, leading from local to cell-wide depolarization and synchronized oscillations that may escalate to the myocardial syncytium generating arrhythmias. Herein, we describe the occurrence of mitochondrial criticality in the chronic setting of a metabolic disorder, type 1 diabetes (T1DM), using a streptozotocin (STZ)-treated guinea pig (GP) animal model. Using wavelet analysis of mitochondrial networks from two-photon microscopy imaging of cardiac myocytes loaded with a fluorescent probe of the mitochondrial membrane potential, we show that cardiomyocytes from T1DM GPs are closer to criticality, making them more vulnerable to cell-wide mitochondrial oscillations as can be judged by the latency period to trigger oscillations after a laser flash perturbation, and their propensity to oscillate. Insulin treatment of T1DM GPs rescued cardiac myocytes to sham control levels of susceptibility, a protective condition that could also be attained with interventions leading to improvement of the cellular redox environment such as preincubation of diabetic cardiac myocytes with the lipid palmitate or a cell-permeable form of glutathione, in the presence of glucose.

Indexed as

cardiac myocytemitochondriamitochondrial criticalitytype 1 diabeteswavelet analysis

Identifiers

PMID32210835
PMCPMC7077512
OpenAlexW3012135032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.